REVEAL GENOMICS Aligns Founder Leadership With Priorities to Support Long-term Growth, Scientific Excellence, and Global Partnerships

The MarketWatch News Department was not involved in the creation of this content.-- The company appoints Joel Parker, Ph.D., as Chief Scientific Officer; Ana Vivancos, Ph.D., as D ...
Morningstar

Dante Omics AI Ushers Genomics Into the AI Age With GPU-Accelerated Proprietary Multiomics Platform

Advanced NVIDIA GPU Integration Transforms Genome and Multiomics Alignment, Variant Calling and Reporting Capabilities Dante Omics AI, a pioneering force in computational genomics, today announced a ...
Labroots

Genomic advances in hereditary cancer: Optimizing variant detection and interpretation workflows

Hereditary cancer risk assessment is a rapidly advancing field, driven by the need for comprehensive variant detection, streamlined genomic workflows, and alignment with evolving guidelines. In the UK ...

Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs and Extends its Operating ...

Beam is building a platform approach for single-course, precision gene editing therapies for liver-targeted genetic diseases by delivering base editors through intravenous infusion of ...